Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sho Kakuto"'
Autor:
Takahiro Akita, Ryo Ariyasu, Sho Kakuto, Keiki Miyadera, Ayu Kiritani, Ryosuke Tsugitomi, Yoshiaki Amino, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Sadatomo Tasaka, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 15, Iss 10, Pp 788-796 (2024)
Abstract Background It is difficult to predict gene mutations individually based on clinical background alone. Tumor markers may help to predict each gene mutation. Identifying tumor markers that can predict gene mutation will facilitate timely genet
Externí odkaz:
https://doaj.org/article/93acc07c0f8341ceb4a0c0b39dc0fe16
Autor:
Yoshiaki Amino, Siew‐Kee Low, Hironori Ninomiya, Ayu Kiritani, Keiki Miyadera, Sho Kakuto, Takahiro Akita, Ryosuke Tsugitomi, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 14, Iss 33, Pp 3317-3322 (2023)
Abstract Background KRAS mutation positive lung cancer is known to be clinically characterized by older age, males, and smokers. It is reported to be more common in mucinous adenocarcinoma, but all reports are based on analysis of tissue samples. Rec
Externí odkaz:
https://doaj.org/article/65050a39348140f4a87a937f35d99782
Autor:
Ryo Ariyasu, MD, Sho Kakuto, MD, Keiki Miyadera, MD, Takahiro Akita, MD, Ayu Kiritani, MD, Ryosuke Tsugitomi, MD, Yoshiaki Amino, MD, Ken Uchibori, MD, PhD, Satoru Kitazono, MD, PhD, Noriko Yanagitani, MD, PhD, Makoto Nishio, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 6, Pp 100524- (2023)
Introduction: Only a few reports have determined whether recently advanced anticancer drugs, particularly next-generation tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs), prolong the survival of patients with NSCLC in the re
Externí odkaz:
https://doaj.org/article/461d74d1b3d4494e8199e62cc0a7c7d3
Autor:
Manami Suzuki, Kentarou Takei, Hisatoshi Sugiura, Kei Sato, Tsutomu Tamada, Koji Murakami, Hirohito Sano, Naoki Tode, Yoko Tsukita, Daisuke Narita, Nozomu Kimura, Shuichiro Matsumoto, Yoshinao Ono, Chikashi Iwasaki, Hatsumi Sugiyama, Sho Kakuto, Shuichi Konno, Hajime Kanamori, Hiroaki Baba, Kengo Oshima, Koichi Tokuda
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Rational Corticosteroid therapy plays a key role in the treatment of COVID-19 patients with respiratory failure. However, a rebound phenomenon after steroid cessation rarely occurs. Here, we investigated the clinical features of patients with rebound
Externí odkaz:
https://doaj.org/article/6088d4c0a91548638130220f7dc5d3ac
Autor:
Koji Murakami, Hirohito Sano, Naoki Tode, Yoko Tsukita, Kei Sato, Daisuke Narita, Nozomu Kimura, Shuichiro Matsumoto, Yoshinao Ono, Chikashi Iwasaki, Hatsumi Sugiyama, Manami Suzuki, Sho Kakuto, Shuichi Konno, Hajime Kanamori, Hiroaki Baba, Kengo Oshima, Kentarou Takei, Koichi Tokuda, Tsutomu Tamada, Hisatoshi Sugiura
Publikováno v:
BMJ Open Respiratory Research. 9:e001332
RationalCorticosteroid therapy plays a key role in the treatment of COVID-19 patients with respiratory failure. However, a rebound phenomenon after steroid cessation rarely occurs. Here, we investigated the clinical features of patients with rebound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e7c7ea3d2c528386619ee5c0946344d
https://doi.org/10.1136/bmjresp-2022-001332
https://doi.org/10.1136/bmjresp-2022-001332